Perez-Stable C, Altman N H, Brown J, Harbison M, Cray C, Roos B A
Geriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Miami, Florida, USA.
Lab Invest. 1996 Feb;74(2):363-73.
Targeted oncogenesis in transgenic mice has unexpectedly produced predictable tissue-specific tumors. We previously showed that hybrid gene constructs of the human fetal G gamma- or mouse embryonic beta h1-globin promoter linked to the viral simian virus 40 T antigen (G gamma/T and beta h1/T) expressed appropriately in embryonic erythroid tissue, with some unexpected expression elsewhere. Tumors arising in the G gamma/T and beta h1/T transgenic mice were identified by histology, electron microscopy, cell culture, and RNase protection analyses. In one G gamma/T transgenic line, males developed prostate tumors that showed mixed neuroendocrine and epithelial cell features, whereas females developed adrenocortical tumors. In several other G gamma/T lines, brown adipose tumors, or hibernomas, developed in the subcutaneous interscapular neck and shoulder area, as well as internally in the periadrenal and pericardial areas. Little or no expression of T antigen was detected in adult animals before visible tumor formation. In contrast, beta h1/T transgenic mice developed only choroid plexus tumors. Transient transfection assays in prostate and adrenocortical tumor-derived cell lines showed that the G gamma-globin promoter is 7-to 10-fold more active than the beta h1-globin promoter. Activity of 5' G gamma-globin promoter-deletion DNA plasmids was analyzed by transient transfection in a variety of human prostate cancer cell lines. The G gamma-globin promoter region between -140 and -201 also showed high activity in the androgen-independent human prostate cancer cell lines DU-145 and PPC-1, but low activity in the androgen-responsive human prostate cell line LNCaP. We conclude that tumor formation in the G gamma/T transgenic lines apparently results from cryptic positive DNA cis elements active in prostate and adrenocortical cells. Because G gamma-globin promoter activity is highest in embryonic tissue, tumors in adult transgenic mice may result from expression of T antigen in embryonic prostate, adrenal glands, and brown adipose tissue.
转基因小鼠中的靶向肿瘤发生意外地产生了可预测的组织特异性肿瘤。我们之前表明,将人胎儿Gγ-或小鼠胚胎βh1-珠蛋白启动子与病毒猿猴病毒40 T抗原(Gγ/T和βh1/T)连接的杂合基因构建体在胚胎红细胞组织中适当表达,在其他地方有一些意外表达。通过组织学、电子显微镜、细胞培养和核糖核酸酶保护分析鉴定了Gγ/T和βh1/T转基因小鼠中出现的肿瘤。在一个Gγ/T转基因品系中,雄性小鼠发生了具有混合神经内分泌和上皮细胞特征的前列腺肿瘤,而雌性小鼠发生了肾上腺皮质肿瘤。在其他几个Gγ/T品系中,棕色脂肪肿瘤或冬眠瘤在肩胛间颈部和肩部皮下区域以及肾上腺周围和心包区域内部形成。在可见肿瘤形成之前,成年动物中几乎检测不到T抗原的表达。相比之下,βh1/T转基因小鼠仅发生脉络丛肿瘤。在前列腺和肾上腺皮质肿瘤衍生的细胞系中进行的瞬时转染试验表明,Gγ-珠蛋白启动子的活性比βh1-珠蛋白启动子高7至10倍。通过在多种人前列腺癌细胞系中进行瞬时转染分析了5' Gγ-珠蛋白启动子缺失DNA质粒的活性。-140至-201之间的Gγ-珠蛋白启动子区域在雄激素非依赖性人前列腺癌细胞系DU-145和PPC-1中也显示出高活性,但在雄激素反应性人前列腺细胞系LNCaP中活性较低。我们得出结论,Gγ/T转基因品系中的肿瘤形成显然是由在前列腺和肾上腺皮质细胞中活跃的隐蔽阳性DNA顺式元件导致的。由于Gγ-珠蛋白启动子活性在胚胎组织中最高,成年转基因小鼠中的肿瘤可能是由于T抗原在胚胎前列腺、肾上腺和棕色脂肪组织中的表达所致。